{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:32:27Z","timestamp":1784698347183,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eat Weight Disord"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/bf03327760","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T10:09:33Z","timestamp":1382350173000},"page":"e53-e56","source":"Crossref","is-referenced-by-count":41,"title":["Olanzapine use in adolescent anorexia nervosa"],"prefix":"10.1007","volume":"11","author":[{"given":"K.","family":"Dennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Le Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,21]]},"reference":[{"key":"BF03327760_CR1","volume-title":"Fluoxetine vs. Placebo to prevent relapse in anorexia nervosa: Primary outcome of drug on time to relapse in 93 weight restored subjects","author":"BT Walsh","year":"2005","unstructured":"Walsh B.T., Kaplan A.S, Attia E., Carter J., Devlin M.J., Olmsted M., Pike K.M., Woodside B., Parides M.: Fluoxetine vs. Placebo to prevent relapse in anorexia nervosa: Primary outcome of drug on time to relapse in 93 weight restored subjects. Paper presented at the Eating Disorders Research Society, Toronto, September, 2005."},{"key":"BF03327760_CR2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1192\/bjp.144.3.288","volume":"144","author":"W Vandereycken","year":"1984","unstructured":"Vandereycken W.: Neuroleptics in the short-term treatment of anorexia nervosa: A double-blind placebo-controlled study with sulpiride. Br. J. Psychiatry, 144, 288\u2013292, 1984.","journal-title":"Br. J. Psychiatry"},{"key":"BF03327760_CR3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/archpsyc.1986.01800020087011","volume":"43","author":"K Halmi","year":"1986","unstructured":"Halmi K., Eckert E., LaDu T., Cohen J.: Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch. Gen. Psychiatry, 43, 177\u2013181, 1986.","journal-title":"Arch. Gen. Psychiatry"},{"key":"BF03327760_CR4","first-page":"41","volume":"52","author":"WH Kaye","year":"1991","unstructured":"Kaye W.H., Weltzin T.E.: Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood. J. Clin. Psychiatry, 52, 41\u201348, 1991.","journal-title":"J. Clin. Psychiatry"},{"key":"BF03327760_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/eat.1054","volume":"30","author":"GK Frank","year":"2001","unstructured":"Frank G.K., Kaye W.H., Weltzin T.E., Perel J., Moss H., McConaha C, Pollice C: Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration. Int. J. Eat. Disord., 30, 57\u201368, 2001.","journal-title":"Int. J. Eat. Disord."},{"key":"BF03327760_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/eat.10115","volume":"33","author":"A Boachie","year":"2003","unstructured":"Boachie A., Goldfield G.S., Spettigue W.: Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa. Int. J. Eat. Disord., 33, 98\u2013103, 2003.","journal-title":"Int. J. Eat. Disord."},{"key":"BF03327760_CR7","unstructured":"Attia E., Kaplan A.S., Schroeder L., Federici A., Staab R.: Atypical antipsychotic medication in anorexia nervosa. Paper presented at the Eating Disorders Research Society, Toronto, September, 2005."},{"key":"BF03327760_CR8","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/j.1440-1614.2005.01536.x","volume":"39","author":"P Bosanac","year":"2005","unstructured":"Bosanac P., Norman T., Burrows G., Beumont P.: Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? Aust. N. Z. J. Psychiatry, 39, 146\u2013153, 2005.","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"BF03327760_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1098-108X(200004)27:3<363::AID-EAT16>3.0.CO;2-5","volume":"27","author":"MC LaVia","year":"2000","unstructured":"LaVia M.C., Gray N, Kaye W.H.: Case reports of olanzapine treatment of anorexia nervosa. Int. J. Eat. Disord., 27, 363\u2013366, 2000.","journal-title":"Int. J. Eat. Disord."},{"key":"BF03327760_CR10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s007870170039","volume":"10","author":"C Mehler","year":"2001","unstructured":"Mehler C., Wewetzer C., Schulze U., Warnke A., Theisen F., Dittmann R.W.: Olanzapine in children and adolescents with chronic anorexia nervosa. Eur. Child. Adolesc. Psychiatry, 10, 151\u2013157, 2001.","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"BF03327760_CR11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/eat.10084","volume":"32","author":"P Powers","year":"2002","unstructured":"Powers P., Santana C., Bannon Y.: Olanzapine in the treatment of anorexia nervosa: an open label trial. Int. J. Eat. Disord., 32, 146\u2013152, 2002.","journal-title":"Int. J. Eat. Disord."},{"key":"BF03327760_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/j.1440-1665.2004.02154.x","volume":"13","author":"N Mondraty","year":"2005","unstructured":"Mondraty N, Birmingham C.L., Touyz S., Sundakov V., Chapman L., Beaumont P.: Randomized controlled trial of olanzapine in the treatment of cognitions in anorexia nervosa. Aust. Psychiatry, 13, 72\u201375, 2005.","journal-title":"Aust. Psychiatry"},{"key":"BF03327760_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J.: An inventory for measuring depression. Arch. Gen. Psychiatry, 4, 561\u2013571, 1961.","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03327760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03327760\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03327760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T01:39:29Z","timestamp":1558575569000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03327760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF03327760"],"URL":"https:\/\/doi.org\/10.1007\/bf03327760","relation":{},"ISSN":["1124-4909","1590-1262"],"issn-type":[{"value":"1124-4909","type":"print"},{"value":"1590-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}